 Vikhyat Bebarta
Concepts (599)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 34 | 2023 | 135 | 12.170 |
Why?
| | Military Personnel | 50 | 2024 | 521 | 9.950 |
Why?
| | Cyanides | 25 | 2023 | 46 | 7.550 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 26 | 7.070 |
Why?
| | Wounds and Injuries | 34 | 2024 | 674 | 6.760 |
Why?
| | Emergency Medical Services | 31 | 2023 | 581 | 6.390 |
Why?
| | Air Ambulances | 15 | 2024 | 34 | 4.420 |
Why?
| | Afghan Campaign 2001- | 31 | 2024 | 162 | 3.850 |
Why?
| | Resuscitation | 13 | 2023 | 221 | 3.820 |
Why?
| | Swine | 36 | 2024 | 687 | 3.690 |
Why?
| | Cobamides | 8 | 2022 | 19 | 3.670 |
Why?
| | Military Medicine | 15 | 2022 | 92 | 3.510 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 3.230 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 40 | 3.010 |
Why?
| | Potassium Cyanide | 8 | 2021 | 18 | 2.880 |
Why?
| | Infusions, Intraosseous | 10 | 2024 | 20 | 2.740 |
Why?
| | Poisoning | 9 | 2023 | 110 | 2.620 |
Why?
| | Critical Care | 12 | 2024 | 472 | 2.590 |
Why?
| | Hypotension | 11 | 2021 | 115 | 2.480 |
Why?
| | Warfare | 12 | 2023 | 74 | 2.390 |
Why?
| | Apnea | 5 | 2020 | 17 | 2.350 |
Why?
| | Hospitals, Military | 9 | 2018 | 32 | 2.270 |
Why?
| | Emergency Medicine | 10 | 2018 | 220 | 2.190 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 771 | 2.120 |
Why?
| | Airway Management | 5 | 2019 | 59 | 2.040 |
Why?
| | Heart Arrest | 7 | 2020 | 293 | 2.040 |
Why?
| | Hydrocodone | 5 | 2019 | 15 | 2.030 |
Why?
| | Disease Models, Animal | 28 | 2023 | 3498 | 2.000 |
Why?
| | Emergency Service, Hospital | 15 | 2019 | 1815 | 1.980 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 151 | 1.910 |
Why?
| | Sulfides | 7 | 2022 | 93 | 1.730 |
Why?
| | Afghanistan | 16 | 2024 | 108 | 1.630 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 28 | 1.610 |
Why?
| | Transportation of Patients | 3 | 2018 | 51 | 1.600 |
Why?
| | Humans | 160 | 2024 | 114043 | 1.550 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 297 | 1.540 |
Why?
| | Analgesics | 4 | 2017 | 156 | 1.530 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 37 | 1.530 |
Why?
| | Critical Illness | 10 | 2023 | 640 | 1.480 |
Why?
| | Injury Severity Score | 16 | 2024 | 472 | 1.440 |
Why?
| | Retrospective Studies | 43 | 2024 | 12521 | 1.380 |
Why?
| | Female | 88 | 2024 | 59325 | 1.360 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 222 | 1.360 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 176 | 1.360 |
Why?
| | Male | 91 | 2024 | 55396 | 1.350 |
Why?
| | Ketamine | 5 | 2020 | 92 | 1.340 |
Why?
| | Shock, Hemorrhagic | 5 | 2023 | 152 | 1.340 |
Why?
| | Airway Obstruction | 3 | 2018 | 160 | 1.310 |
Why?
| | Animals | 61 | 2024 | 31565 | 1.310 |
Why?
| | Heart Massage | 3 | 2019 | 7 | 1.300 |
Why?
| | Research | 6 | 2022 | 389 | 1.300 |
Why?
| | Toxicology | 4 | 2018 | 35 | 1.270 |
Why?
| | Drug Overdose | 10 | 2016 | 292 | 1.260 |
Why?
| | Pressure | 2 | 2020 | 214 | 1.220 |
Why?
| | Adult | 62 | 2024 | 30375 | 1.210 |
Why?
| | Patient Transfer | 3 | 2019 | 142 | 1.210 |
Why?
| | Poison Control Centers | 8 | 2017 | 84 | 1.200 |
Why?
| | Registries | 18 | 2024 | 1764 | 1.190 |
Why?
| | Intubation, Intratracheal | 8 | 2023 | 214 | 1.180 |
Why?
| | Respiration, Artificial | 6 | 2023 | 528 | 1.170 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 413 | 1.160 |
Why?
| | Brugada Syndrome | 4 | 2008 | 8 | 1.150 |
Why?
| | Prospective Studies | 27 | 2024 | 6195 | 1.140 |
Why?
| | Hemorrhage | 9 | 2023 | 600 | 1.110 |
Why?
| | United States | 41 | 2024 | 12137 | 1.100 |
Why?
| | Amitriptyline | 4 | 2011 | 20 | 1.080 |
Why?
| | Sodium Nitrite | 4 | 2016 | 37 | 1.040 |
Why?
| | Pain Measurement | 3 | 2018 | 441 | 1.040 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 40 | 1.020 |
Why?
| | Random Allocation | 7 | 2020 | 328 | 1.020 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 133 | 1.000 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 0.990 |
Why?
| | Injections, Intramuscular | 7 | 2023 | 117 | 0.990 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 62 | 0.990 |
Why?
| | Hemodynamics | 11 | 2023 | 1015 | 0.970 |
Why?
| | Pain Management | 4 | 2020 | 285 | 0.970 |
Why?
| | Hydromorphone | 3 | 2016 | 8 | 0.970 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 68 | 0.960 |
Why?
| | Blood Transfusion | 7 | 2023 | 265 | 0.950 |
Why?
| | Heart Ventricles | 3 | 2020 | 723 | 0.930 |
Why?
| | Blood Pressure | 10 | 2018 | 1531 | 0.920 |
Why?
| | Acute Pain | 2 | 2015 | 35 | 0.920 |
Why?
| | Remote Consultation | 2 | 2015 | 42 | 0.910 |
Why?
| | War-Related Injuries | 3 | 2021 | 33 | 0.910 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 193 | 0.900 |
Why?
| | Environmental Exposure | 4 | 2019 | 372 | 0.880 |
Why?
| | Time Factors | 15 | 2024 | 6077 | 0.880 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 345 | 0.870 |
Why?
| | Tandem Mass Spectrometry | 5 | 2022 | 410 | 0.860 |
Why?
| | Internship and Residency | 4 | 2016 | 920 | 0.850 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.840 |
Why?
| | Snake Bites | 5 | 2019 | 54 | 0.840 |
Why?
| | Sus scrofa | 7 | 2020 | 45 | 0.840 |
Why?
| | Laryngoscopy | 4 | 2023 | 90 | 0.820 |
Why?
| | Young Adult | 28 | 2021 | 10444 | 0.810 |
Why?
| | Compartment Syndromes | 1 | 2022 | 29 | 0.770 |
Why?
| | Acetylcysteine | 2 | 2014 | 141 | 0.750 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 39 | 0.750 |
Why?
| | Administration, Intravenous | 5 | 2019 | 122 | 0.740 |
Why?
| | Laryngoscopes | 3 | 2023 | 38 | 0.730 |
Why?
| | Pain | 5 | 2018 | 701 | 0.730 |
Why?
| | Burns | 4 | 2017 | 237 | 0.720 |
Why?
| | Acetaminophen | 3 | 2014 | 241 | 0.720 |
Why?
| | Cannabinoids | 2 | 2012 | 115 | 0.710 |
Why?
| | Firearms | 3 | 2022 | 300 | 0.700 |
Why?
| | Iraq | 8 | 2023 | 81 | 0.700 |
Why?
| | Patient Handoff | 1 | 2020 | 26 | 0.700 |
Why?
| | Morphine | 3 | 2017 | 121 | 0.700 |
Why?
| | Epinephrine | 5 | 2022 | 163 | 0.690 |
Why?
| | Thorax | 1 | 2020 | 41 | 0.690 |
Why?
| | Balloon Occlusion | 1 | 2020 | 23 | 0.680 |
Why?
| | Thiadiazoles | 1 | 2020 | 21 | 0.680 |
Why?
| | Administration, Oral | 6 | 2021 | 725 | 0.670 |
Why?
| | Trauma Centers | 4 | 2020 | 347 | 0.670 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 370 | 0.660 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.660 |
Why?
| | Antivenins | 4 | 2013 | 56 | 0.630 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 7 | 0.630 |
Why?
| | Blast Injuries | 5 | 2021 | 39 | 0.630 |
Why?
| | Glycine | 1 | 2019 | 152 | 0.610 |
Why?
| | Humerus | 3 | 2022 | 40 | 0.610 |
Why?
| | Nursing Care | 1 | 2018 | 30 | 0.610 |
Why?
| | Chronic Pain | 3 | 2020 | 208 | 0.600 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 224 | 0.600 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 51 | 0.600 |
Why?
| | Norepinephrine | 1 | 2019 | 201 | 0.600 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 22 | 0.600 |
Why?
| | Preceptorship | 1 | 2018 | 62 | 0.600 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 15 | 0.590 |
Why?
| | Emergency Treatment | 4 | 2018 | 113 | 0.590 |
Why?
| | Military Facilities | 1 | 2017 | 2 | 0.590 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 248 | 0.590 |
Why?
| | Tablets | 1 | 2017 | 36 | 0.580 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 125 | 0.580 |
Why?
| | Hypocalcemia | 3 | 2023 | 30 | 0.580 |
Why?
| | Aorta | 1 | 2020 | 388 | 0.570 |
Why?
| | Treatment Outcome | 16 | 2023 | 9049 | 0.570 |
Why?
| | Hyperoxia | 4 | 2023 | 99 | 0.570 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 4 | 0.560 |
Why?
| | Altitude | 1 | 2020 | 435 | 0.540 |
Why?
| | Telemedicine | 2 | 2015 | 662 | 0.540 |
Why?
| | Abdominal Pain | 2 | 2019 | 134 | 0.540 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.540 |
Why?
| | Oseltamivir | 1 | 2016 | 11 | 0.540 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 942 | 0.530 |
Why?
| | Adolescent | 25 | 2021 | 17800 | 0.530 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 19 | 0.530 |
Why?
| | Tourniquets | 3 | 2021 | 27 | 0.530 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 40 | 0.520 |
Why?
| | Tranexamic Acid | 3 | 2023 | 34 | 0.510 |
Why?
| | Antifibrinolytic Agents | 3 | 2023 | 43 | 0.510 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 78 | 0.510 |
Why?
| | Tibia | 2 | 2014 | 166 | 0.500 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 813 | 0.500 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 27 | 0.500 |
Why?
| | Hematinics | 1 | 2015 | 18 | 0.480 |
Why?
| | Electrocardiography | 5 | 2012 | 561 | 0.480 |
Why?
| | Asphyxia | 1 | 2014 | 21 | 0.480 |
Why?
| | Diphenhydramine | 2 | 2015 | 30 | 0.470 |
Why?
| | Patient Simulation | 1 | 2014 | 29 | 0.470 |
Why?
| | Middle Aged | 28 | 2021 | 26605 | 0.470 |
Why?
| | Self Report | 2 | 2017 | 695 | 0.470 |
Why?
| | Efficiency | 1 | 2015 | 84 | 0.460 |
Why?
| | Awards and Prizes | 1 | 2015 | 56 | 0.450 |
Why?
| | Anemia | 1 | 2015 | 143 | 0.450 |
Why?
| | Solvents | 2 | 2004 | 104 | 0.450 |
Why?
| | Tracheotomy | 1 | 2014 | 21 | 0.450 |
Why?
| | Dietary Supplements | 1 | 2017 | 459 | 0.450 |
Why?
| | Exsanguination | 1 | 2013 | 15 | 0.450 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1175 | 0.440 |
Why?
| | Tracheostomy | 1 | 2015 | 97 | 0.440 |
Why?
| | Incidence | 10 | 2022 | 2314 | 0.440 |
Why?
| | Texas | 5 | 2017 | 188 | 0.440 |
Why?
| | Seizures | 3 | 2013 | 337 | 0.420 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 6 | 0.420 |
Why?
| | Mobile Health Units | 2 | 2012 | 18 | 0.420 |
Why?
| | Mass Screening | 2 | 2018 | 979 | 0.420 |
Why?
| | Glyoxylates | 2 | 2023 | 9 | 0.410 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 125 | 0.410 |
Why?
| | Aerospace Medicine | 3 | 2017 | 19 | 0.410 |
Why?
| | Forensic Medicine | 1 | 2012 | 16 | 0.410 |
Why?
| | Methanol | 2 | 2016 | 29 | 0.410 |
Why?
| | Viperidae | 2 | 2011 | 11 | 0.400 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 492 | 0.400 |
Why?
| | Metformin | 1 | 2015 | 274 | 0.390 |
Why?
| | Education, Medical | 1 | 2014 | 214 | 0.390 |
Why?
| | Referral and Consultation | 1 | 2016 | 632 | 0.390 |
Why?
| | Hyperalgesia | 1 | 2012 | 107 | 0.380 |
Why?
| | Renal Dialysis | 1 | 2015 | 375 | 0.380 |
Why?
| | Vitamin B 12 | 1 | 2012 | 115 | 0.380 |
Why?
| | Fires | 1 | 2012 | 73 | 0.380 |
Why?
| | Gait | 1 | 2014 | 250 | 0.380 |
Why?
| | Bone and Bones | 1 | 2014 | 277 | 0.380 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 121 | 0.370 |
Why?
| | Fluid Therapy | 3 | 2019 | 121 | 0.370 |
Why?
| | Survival Rate | 6 | 2018 | 1638 | 0.370 |
Why?
| | Lung | 2 | 2020 | 3521 | 0.370 |
Why?
| | Injections, Intravenous | 5 | 2018 | 198 | 0.360 |
Why?
| | Extremities | 2 | 2022 | 111 | 0.360 |
Why?
| | Antiviral Agents | 1 | 2016 | 642 | 0.360 |
Why?
| | Waiting Lists | 1 | 2012 | 206 | 0.360 |
Why?
| | Influenza, Human | 1 | 2016 | 543 | 0.360 |
Why?
| | Medical Records | 2 | 2021 | 153 | 0.340 |
Why?
| | Guideline Adherence | 4 | 2023 | 489 | 0.320 |
Why?
| | Survival Analysis | 4 | 2021 | 1206 | 0.320 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 38 | 0.320 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 15 | 0.310 |
Why?
| | Omeprazole | 1 | 2008 | 5 | 0.310 |
Why?
| | Vascular Resistance | 3 | 2015 | 340 | 0.310 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 16 | 0.300 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1168 | 0.300 |
Why?
| | Hyponatremia | 1 | 2008 | 37 | 0.300 |
Why?
| | Physicians | 5 | 2019 | 765 | 0.300 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.290 |
Why?
| | Coma | 2 | 2022 | 30 | 0.290 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 949 | 0.290 |
Why?
| | Oxygen | 3 | 2021 | 851 | 0.290 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1011 | 0.290 |
Why?
| | Infant | 10 | 2021 | 7943 | 0.290 |
Why?
| | South Africa | 3 | 2023 | 160 | 0.290 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 69 | 0.290 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1381 | 0.290 |
Why?
| | Delirium | 1 | 2008 | 66 | 0.280 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 94 | 0.280 |
Why?
| | Child, Preschool | 10 | 2021 | 9114 | 0.280 |
Why?
| | Cohort Studies | 6 | 2023 | 4883 | 0.280 |
Why?
| | Thiocyanates | 4 | 2016 | 29 | 0.280 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.280 |
Why?
| | Linear Models | 3 | 2015 | 768 | 0.270 |
Why?
| | Methicillin Resistance | 1 | 2006 | 19 | 0.270 |
Why?
| | Formates | 1 | 2006 | 13 | 0.270 |
Why?
| | Zebrafish | 2 | 2022 | 412 | 0.270 |
Why?
| | Explosions | 2 | 2021 | 11 | 0.270 |
Why?
| | Blindness | 1 | 2006 | 36 | 0.270 |
Why?
| | Poisons | 2 | 2019 | 21 | 0.260 |
Why?
| | Hypothermia | 2 | 2024 | 37 | 0.260 |
Why?
| | Fentanyl | 2 | 2017 | 67 | 0.260 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 813 | 0.260 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 9 | 0.260 |
Why?
| | Intention | 1 | 2007 | 142 | 0.260 |
Why?
| | Rabbits | 5 | 2021 | 733 | 0.260 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2019 | 127 | 0.260 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 126 | 0.260 |
Why?
| | Hospitals | 2 | 2022 | 581 | 0.250 |
Why?
| | Double-Blind Method | 2 | 2015 | 1656 | 0.250 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 54 | 0.250 |
Why?
| | Cannabis | 1 | 2012 | 383 | 0.250 |
Why?
| | Child | 15 | 2021 | 18400 | 0.240 |
Why?
| | Travel | 2 | 2016 | 121 | 0.240 |
Why?
| | Cocaine | 1 | 2007 | 152 | 0.240 |
Why?
| | Surveys and Questionnaires | 8 | 2017 | 4595 | 0.240 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1331 | 0.240 |
Why?
| | Suicide, Attempted | 4 | 2015 | 316 | 0.240 |
Why?
| | Crotalid Venoms | 2 | 2011 | 31 | 0.240 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 27 | 0.240 |
Why?
| | Research Design | 3 | 2015 | 919 | 0.240 |
Why?
| | Echocardiography | 2 | 2018 | 569 | 0.240 |
Why?
| | Pilot Projects | 4 | 2023 | 1360 | 0.230 |
Why?
| | Risk | 2 | 2018 | 810 | 0.230 |
Why?
| | Terpenes | 1 | 2004 | 21 | 0.230 |
Why?
| | Hydrocarbons | 1 | 2004 | 29 | 0.230 |
Why?
| | Limit of Detection | 3 | 2012 | 53 | 0.230 |
Why?
| | Crotalus | 1 | 2004 | 18 | 0.220 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2272 | 0.220 |
Why?
| | Animal Experimentation | 1 | 2003 | 5 | 0.220 |
Why?
| | Neck Injuries | 1 | 2023 | 17 | 0.220 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 151 | 0.220 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 76 | 0.220 |
Why?
| | Models, Animal | 2 | 2024 | 340 | 0.210 |
Why?
| | Shock, Traumatic | 1 | 2023 | 15 | 0.210 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 385 | 0.210 |
Why?
| | Plant Extracts | 1 | 2004 | 154 | 0.200 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 52 | 0.200 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 340 | 0.200 |
Why?
| | Fibrinolysis | 1 | 2023 | 126 | 0.200 |
Why?
| | Follow-Up Studies | 5 | 2017 | 4392 | 0.200 |
Why?
| | Seasons | 1 | 2024 | 440 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2023 | 735 | 0.200 |
Why?
| | Memory | 1 | 2023 | 209 | 0.190 |
Why?
| | Consensus | 3 | 2021 | 532 | 0.190 |
Why?
| | Toxicokinetics | 2 | 2018 | 9 | 0.190 |
Why?
| | Heart Rate | 3 | 2015 | 710 | 0.190 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 156 | 0.180 |
Why?
| | Emergency Responders | 1 | 2021 | 33 | 0.180 |
Why?
| | Soil Pollutants | 1 | 2020 | 14 | 0.180 |
Why?
| | Lactates | 2 | 2012 | 78 | 0.180 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 50 | 0.180 |
Why?
| | Guidelines as Topic | 3 | 2017 | 241 | 0.180 |
Why?
| | Disulfides | 1 | 2020 | 90 | 0.180 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 13 | 0.170 |
Why?
| | Inhalation Exposure | 1 | 2020 | 96 | 0.170 |
Why?
| | Wounds, Nonpenetrating | 2 | 2021 | 249 | 0.170 |
Why?
| | Calcium | 2 | 2023 | 1089 | 0.170 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 122 | 0.170 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 641 | 0.170 |
Why?
| | Brain Injuries | 2 | 2023 | 459 | 0.170 |
Why?
| | Ketorolac | 1 | 2019 | 16 | 0.160 |
Why?
| | Haloperidol | 1 | 2019 | 35 | 0.160 |
Why?
| | Agkistrodon | 1 | 2019 | 19 | 0.160 |
Why?
| | Gases | 1 | 2019 | 38 | 0.160 |
Why?
| | Biomarkers | 3 | 2019 | 3397 | 0.160 |
Why?
| | Logistic Models | 3 | 2024 | 1829 | 0.160 |
Why?
| | Reproducibility of Results | 3 | 2013 | 2764 | 0.160 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 4 | 0.160 |
Why?
| | Harm Reduction | 1 | 2019 | 24 | 0.160 |
Why?
| | Documentation | 1 | 2020 | 166 | 0.160 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.160 |
Why?
| | Blood Circulation | 1 | 2018 | 36 | 0.160 |
Why?
| | Terrorism | 1 | 2018 | 23 | 0.160 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 8 | 0.150 |
Why?
| | Saliva | 1 | 2019 | 188 | 0.150 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 24 | 0.150 |
Why?
| | Torso | 1 | 2018 | 28 | 0.150 |
Why?
| | War Exposure | 1 | 2018 | 10 | 0.150 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 3 | 0.150 |
Why?
| | Vascular Access Devices | 1 | 2018 | 24 | 0.150 |
Why?
| | Tramadol | 1 | 2017 | 9 | 0.150 |
Why?
| | Drug Prescriptions | 2 | 2020 | 237 | 0.150 |
Why?
| | Blood Proteins | 1 | 2019 | 222 | 0.150 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.150 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.150 |
Why?
| | Analysis of Variance | 2 | 2017 | 1218 | 0.150 |
Why?
| | Tidal Volume | 1 | 2018 | 75 | 0.140 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 20 | 0.140 |
Why?
| | Blood Component Transfusion | 1 | 2018 | 63 | 0.140 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 363 | 0.140 |
Why?
| | Disease Management | 3 | 2017 | 556 | 0.140 |
Why?
| | Acidosis | 2 | 2009 | 86 | 0.140 |
Why?
| | Hemoglobins | 2 | 2018 | 308 | 0.140 |
Why?
| | Rescue Work | 1 | 2017 | 8 | 0.140 |
Why?
| | Blood Coagulation | 1 | 2018 | 200 | 0.140 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 384 | 0.140 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 54 | 0.140 |
Why?
| | Shock, Septic | 1 | 2019 | 185 | 0.140 |
Why?
| | Epidemics | 1 | 2018 | 66 | 0.140 |
Why?
| | Inpatients | 1 | 2020 | 378 | 0.140 |
Why?
| | Educational Status | 2 | 2016 | 408 | 0.140 |
Why?
| | Dextromethorphan | 1 | 2016 | 19 | 0.140 |
Why?
| | Headache | 1 | 2017 | 132 | 0.140 |
Why?
| | Burns, Chemical | 1 | 2017 | 25 | 0.140 |
Why?
| | Medical Errors | 1 | 2017 | 86 | 0.140 |
Why?
| | Algorithms | 2 | 2016 | 1469 | 0.140 |
Why?
| | Antacids | 1 | 2016 | 13 | 0.140 |
Why?
| | Telephone | 1 | 2017 | 152 | 0.140 |
Why?
| | Sodium Chloride | 1 | 2017 | 133 | 0.140 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1117 | 0.130 |
Why?
| | Prognosis | 2 | 2019 | 3315 | 0.130 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 83 | 0.130 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 296 | 0.130 |
Why?
| | Clinical Protocols | 1 | 2018 | 232 | 0.130 |
Why?
| | Breast Neoplasms | 1 | 2007 | 1846 | 0.130 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 80 | 0.130 |
Why?
| | Decision Trees | 1 | 2016 | 82 | 0.130 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2023 | 1204 | 0.130 |
Why?
| | Proteome | 1 | 2019 | 337 | 0.130 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 29 | 0.130 |
Why?
| | Sepsis | 1 | 2021 | 507 | 0.130 |
Why?
| | Brain Concussion | 1 | 2023 | 477 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 182 | 0.130 |
Why?
| | Heart Diseases | 1 | 2019 | 329 | 0.130 |
Why?
| | Massachusetts | 1 | 2016 | 134 | 0.130 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 12 | 0.130 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 4402 | 0.130 |
Why?
| | Benzodiazepines | 1 | 2016 | 114 | 0.130 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 247 | 0.130 |
Why?
| | Radiation Injuries | 1 | 2017 | 128 | 0.130 |
Why?
| | Drug Costs | 1 | 2016 | 92 | 0.130 |
Why?
| | Clinical Competence | 2 | 2014 | 882 | 0.130 |
Why?
| | Disaster Planning | 1 | 2016 | 74 | 0.130 |
Why?
| | Methotrexate | 1 | 2016 | 227 | 0.120 |
Why?
| | Metabolome | 1 | 2018 | 274 | 0.120 |
Why?
| | Drug Utilization Review | 1 | 2015 | 56 | 0.120 |
Why?
| | Angiography | 2 | 2013 | 176 | 0.120 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1078 | 0.120 |
Why?
| | Phenols | 1 | 2015 | 82 | 0.120 |
Why?
| | Equipment Design | 2 | 2024 | 503 | 0.120 |
Why?
| | Length of Stay | 2 | 2016 | 957 | 0.120 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 15 | 0.120 |
Why?
| | Aged, 80 and over | 3 | 2016 | 6306 | 0.120 |
Why?
| | Nurses | 1 | 2016 | 145 | 0.120 |
Why?
| | Vitamin B Complex | 1 | 2014 | 38 | 0.120 |
Why?
| | Societies, Medical | 1 | 2018 | 655 | 0.120 |
Why?
| | Mortality | 1 | 2016 | 283 | 0.110 |
Why?
| | Anesthesia, General | 1 | 2014 | 44 | 0.110 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 4 | 0.110 |
Why?
| | Shock | 2 | 2012 | 83 | 0.110 |
Why?
| | Anesthetics | 1 | 2014 | 54 | 0.110 |
Why?
| | Proteomics | 1 | 2019 | 815 | 0.110 |
Why?
| | Health Services Research | 1 | 2016 | 373 | 0.110 |
Why?
| | Teaching Rounds | 1 | 2015 | 64 | 0.110 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 85 | 0.110 |
Why?
| | Mentors | 1 | 2015 | 155 | 0.110 |
Why?
| | Liver Function Tests | 1 | 2014 | 103 | 0.110 |
Why?
| | Thiazoles | 1 | 2014 | 110 | 0.110 |
Why?
| | Academic Medical Centers | 1 | 2016 | 405 | 0.110 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 15 | 0.110 |
Why?
| | Metabolomics | 1 | 2018 | 511 | 0.110 |
Why?
| | Ischemia | 2 | 2014 | 361 | 0.110 |
Why?
| | Alanine Transaminase | 1 | 2014 | 141 | 0.110 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 140 | 0.110 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 239 | 0.110 |
Why?
| | Necrosis | 1 | 2014 | 209 | 0.110 |
Why?
| | Drug Combinations | 1 | 2014 | 286 | 0.110 |
Why?
| | Health Surveys | 1 | 2015 | 441 | 0.110 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 1836 | 0.100 |
Why?
| | Data Collection | 1 | 2015 | 618 | 0.100 |
Why?
| | Nitriles | 1 | 2013 | 149 | 0.100 |
Why?
| | Tertiary Healthcare | 1 | 2012 | 28 | 0.100 |
Why?
| | Common Cold | 1 | 2012 | 12 | 0.100 |
Why?
| | Drug Stability | 1 | 2013 | 151 | 0.100 |
Why?
| | Respiratory System Agents | 1 | 2012 | 22 | 0.100 |
Why?
| | Cues | 1 | 2014 | 301 | 0.100 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 22 | 0.100 |
Why?
| | Safety | 2 | 2013 | 298 | 0.100 |
Why?
| | Cadaver | 2 | 2024 | 298 | 0.100 |
Why?
| | Basilar Artery | 1 | 2012 | 6 | 0.100 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 90 | 0.100 |
Why?
| | Risk Assessment | 2 | 2018 | 2958 | 0.100 |
Why?
| | Aged | 6 | 2019 | 18969 | 0.100 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 68 | 0.100 |
Why?
| | Triage | 2 | 2017 | 197 | 0.100 |
Why?
| | Cough | 1 | 2012 | 107 | 0.100 |
Why?
| | Fever | 1 | 2013 | 280 | 0.100 |
Why?
| | Femur | 1 | 2013 | 191 | 0.100 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 75 | 0.090 |
Why?
| | Mice | 4 | 2023 | 14841 | 0.090 |
Why?
| | Patient Satisfaction | 1 | 2015 | 571 | 0.090 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 22 | 0.090 |
Why?
| | Pain, Postoperative | 1 | 2012 | 190 | 0.090 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 507 | 0.090 |
Why?
| | Health Care Surveys | 1 | 2012 | 541 | 0.090 |
Why?
| | Drug Administration Routes | 1 | 2010 | 38 | 0.090 |
Why?
| | Needlestick Injuries | 1 | 2010 | 4 | 0.090 |
Why?
| | Sleep Stages | 1 | 2010 | 61 | 0.090 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 204 | 0.090 |
Why?
| | Nausea | 1 | 2010 | 99 | 0.080 |
Why?
| | Curriculum | 1 | 2015 | 813 | 0.080 |
Why?
| | Vomiting | 1 | 2010 | 122 | 0.080 |
Why?
| | Mental Health | 1 | 2015 | 559 | 0.080 |
Why?
| | Tympanic Membrane Perforation | 1 | 2009 | 12 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 231 | 0.080 |
Why?
| | Manikins | 1 | 2009 | 23 | 0.080 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 757 | 0.080 |
Why?
| | Allied Health Personnel | 1 | 2009 | 42 | 0.080 |
Why?
| | Electronic Health Records | 1 | 2015 | 799 | 0.080 |
Why?
| | Patient Care Team | 1 | 2013 | 517 | 0.080 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1690 | 0.080 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 175 | 0.080 |
Why?
| | Inservice Training | 1 | 2009 | 106 | 0.070 |
Why?
| | Risk Factors | 5 | 2017 | 8614 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 282 | 0.070 |
Why?
| | Primary Health Care | 2 | 2020 | 1502 | 0.070 |
Why?
| | Thoracostomy | 1 | 2007 | 16 | 0.070 |
Why?
| | Anaphylaxis | 1 | 2010 | 144 | 0.070 |
Why?
| | Decision Support Techniques | 1 | 2011 | 336 | 0.070 |
Why?
| | Spectrum Analysis | 2 | 2018 | 83 | 0.070 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2537 | 0.070 |
Why?
| | Fatal Outcome | 1 | 2007 | 281 | 0.070 |
Why?
| | Sodium Channels | 1 | 2007 | 61 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2012 | 756 | 0.070 |
Why?
| | Vasopressins | 1 | 2006 | 56 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2019 | 587 | 0.070 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 4 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 113 | 0.060 |
Why?
| | Propylamines | 1 | 2005 | 11 | 0.060 |
Why?
| | Death, Sudden | 1 | 2005 | 26 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 330 | 0.060 |
Why?
| | Valproic Acid | 1 | 2005 | 43 | 0.060 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 117 | 0.060 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 17 | 0.060 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 139 | 0.060 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 60 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 637 | 0.060 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanones | 1 | 2004 | 1 | 0.060 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.060 |
Why?
| | Hexanes | 1 | 2004 | 3 | 0.060 |
Why?
| | Cyclohexenes | 1 | 2004 | 6 | 0.060 |
Why?
| | Parents | 1 | 2012 | 1181 | 0.060 |
Why?
| | Alkanes | 1 | 2004 | 14 | 0.060 |
Why?
| | Oleic Acid | 1 | 2004 | 30 | 0.060 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 42 | 0.060 |
Why?
| | Linoleic Acid | 1 | 2004 | 37 | 0.060 |
Why?
| | Catheters | 1 | 2024 | 64 | 0.060 |
Why?
| | Electric Power Supplies | 1 | 2024 | 48 | 0.060 |
Why?
| | Charcoal | 1 | 2004 | 23 | 0.060 |
Why?
| | Rats | 2 | 2022 | 4913 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2004 | 50 | 0.060 |
Why?
| | Sorbitol | 1 | 2023 | 15 | 0.060 |
Why?
| | Anticonvulsants | 1 | 2005 | 178 | 0.060 |
Why?
| | Half-Life | 2 | 2014 | 141 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2004 | 52 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 63 | 0.050 |
Why?
| | Observer Variation | 1 | 2004 | 298 | 0.050 |
Why?
| | Fibrinogen | 1 | 2004 | 143 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 48 | 0.050 |
Why?
| | Video Recording | 1 | 2023 | 141 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2019 | 465 | 0.050 |
Why?
| | Hemostasis | 1 | 2023 | 64 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 330 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2023 | 55 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 76 | 0.050 |
Why?
| | Hypertension | 1 | 2010 | 1052 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 156 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 42 | 0.050 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 154 | 0.050 |
Why?
| | Armed Conflicts | 1 | 2021 | 14 | 0.050 |
Why?
| | Bandages | 1 | 2021 | 30 | 0.050 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2182 | 0.050 |
Why?
| | Cricetulus | 1 | 2021 | 97 | 0.050 |
Why?
| | CHO Cells | 1 | 2021 | 137 | 0.050 |
Why?
| | Sheep | 1 | 2004 | 761 | 0.050 |
Why?
| | Aviation | 1 | 2021 | 9 | 0.050 |
Why?
| | Fumigation | 1 | 2020 | 2 | 0.050 |
Why?
| | Cricetinae | 1 | 2021 | 252 | 0.050 |
Why?
| | Age Factors | 2 | 2019 | 2885 | 0.050 |
Why?
| | Hydrazines | 1 | 2021 | 27 | 0.050 |
Why?
| | Oximetry | 1 | 2021 | 79 | 0.050 |
Why?
| | Hemolysis | 1 | 2022 | 143 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2021 | 249 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 49 | 0.040 |
Why?
| | Plasma | 1 | 2022 | 181 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2007 | 932 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 241 | 0.040 |
Why?
| | Quality Improvement | 2 | 2021 | 944 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 55 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 161 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 945 | 0.040 |
Why?
| | Hospitalization | 2 | 2019 | 1762 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1558 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 41 | 0.040 |
Why?
| | Infant, Newborn | 2 | 2021 | 5038 | 0.040 |
Why?
| | Hippocampus | 1 | 2023 | 690 | 0.040 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.040 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
| | North America | 1 | 2019 | 255 | 0.040 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 53 | 0.040 |
Why?
| | Drug Storage | 1 | 2018 | 57 | 0.040 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1422 | 0.040 |
Why?
| | Resource Allocation | 1 | 2018 | 37 | 0.040 |
Why?
| | Peptides | 1 | 2023 | 848 | 0.040 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 100 | 0.040 |
Why?
| | Multiple Trauma | 1 | 2018 | 87 | 0.040 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 183 | 0.040 |
Why?
| | Carbon Dioxide | 1 | 2018 | 218 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 561 | 0.030 |
Why?
| | Burn Units | 1 | 2016 | 26 | 0.030 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 119 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 666 | 0.030 |
Why?
| | Qualitative Research | 1 | 2020 | 919 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 207 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 87 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1277 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 917 | 0.030 |
Why?
| | Hypoxia | 1 | 2021 | 956 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 158 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 573 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 1791 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 11 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 134 | 0.030 |
Why?
| | Eating | 1 | 2016 | 344 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 78 | 0.030 |
Why?
| | Thiazolidines | 1 | 2013 | 7 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2013 | 25 | 0.030 |
Why?
| | Indicators and Reagents | 1 | 2013 | 99 | 0.030 |
Why?
| | Educational Measurement | 1 | 2015 | 235 | 0.030 |
Why?
| | Teaching | 1 | 2015 | 209 | 0.030 |
Why?
| | Isotonic Solutions | 1 | 2013 | 34 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2014 | 184 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1080 | 0.030 |
Why?
| | Critical Care Nursing | 1 | 2013 | 28 | 0.030 |
Why?
| | Species Specificity | 1 | 2014 | 541 | 0.030 |
Why?
| | Traumatology | 1 | 2012 | 22 | 0.030 |
Why?
| | Quality Control | 1 | 2012 | 143 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3003 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 236 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 46 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 99 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 568 | 0.020 |
Why?
| | Organizational Innovation | 1 | 2012 | 132 | 0.020 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 172 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 254 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 157 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2464 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 295 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 81 | 0.020 |
Why?
| | Injections | 1 | 2010 | 160 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 9 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1447 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 302 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 26 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 95 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 134 | 0.020 |
Why?
| | Electric Countershock | 1 | 2006 | 104 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2007 | 217 | 0.020 |
Why?
| | Delivery of Health Care | 1 | 2012 | 828 | 0.020 |
Why?
| | Haplorhini | 1 | 2005 | 57 | 0.020 |
Why?
| | Postoperative Complications | 1 | 2013 | 2122 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3039 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|